Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liqing Hu

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|July 26, 2024
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial HypertensionYuanbo Hu, Congke Zhao, Wenhua Tan, et al.
BMC Pulmonary Medicine|July 27, 2023
Retrospective analysis of pulmonary cryptococcosis and extrapulmonary cryptococcosis in a chinese tertiary hospitalJiejun Shi, Jianhua Chen, Liqing Hu, et al.
Frontiers in Neurology|May 14, 2026
Low-dose versus standard-dose intravenous immunoglobulin in generalized myasthenia gravis: a prospective single-center cohort studyHaocheng Luo, Li Dong, Li Yang, et al.
Journal of Medicinal Chemistry|September 11, 2020
Discovery of Novel Pyrazolo[3,4-<i>b</i>] Pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial HypertensionLiqing Hu, Lijun Li, Qi Chang, et al.
Journal of Medicinal Chemistry|May 11, 2026
Identification of an Hsp110/HDAC6 Dual-Target Inhibitor for the Effective Treatment of Pulmonary Arterial Hypertension via Synergistic Blockade of Vascular RemodelingMengqi Li, Yu Wang, Xinru Liang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2024
Inhibition of breast cancer growth with AN-329, a novel Hsp110 inhibitor, by inactivating p-STAT3/c-Myc axisJunnan Li, Ruizhe Gao, Congke Zhao, et al.
Journal of Medicinal Chemistry|December 13, 2025
Design and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting Extracellular Matrix Dysregulation and Vasodilation for the Treatment of Pulmonary Arterial HypertensionYuanbo Hu, Yu Wang, Wenhua Tan, et al.
Journal of Medicinal Chemistry|April 22, 2026
Identification of Nitric Oxide-Donating Lenumlostat Derivatives with Dual Activities of Extracellular Matrix Dysregulation Inhibition and Pulmonary Vasodilation for the Treatment of Pulmonary Arterial HypertensionYuanbo Hu, Yu Wang, Wenhua Tan, et al.
Frontiers in Microbiology|December 17, 2024
Molecular characteristics, clonal transmission, and risk factors of <i>Clostridioides difficile</i> among hospitalized patients in a tertiary hospital in Ningbo, ChinaLiqing Hu, Shan Lin, Meng Zhang, et al.
Nature Communications|May 12, 2023
A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungiLiqing Hu, Cancan Sun, Justin M Kidd, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|July 26, 2024
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial HypertensionYuanbo Hu, Congke Zhao, Wenhua Tan, et al.
BMC Pulmonary Medicine|July 27, 2023
Retrospective analysis of pulmonary cryptococcosis and extrapulmonary cryptococcosis in a chinese tertiary hospitalJiejun Shi, Jianhua Chen, Liqing Hu, et al.
Frontiers in Neurology|May 14, 2026
Low-dose versus standard-dose intravenous immunoglobulin in generalized myasthenia gravis: a prospective single-center cohort studyHaocheng Luo, Li Dong, Li Yang, et al.
Journal of Medicinal Chemistry|September 11, 2020
Discovery of Novel Pyrazolo[3,4-<i>b</i>] Pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial HypertensionLiqing Hu, Lijun Li, Qi Chang, et al.
Journal of Medicinal Chemistry|May 11, 2026
Identification of an Hsp110/HDAC6 Dual-Target Inhibitor for the Effective Treatment of Pulmonary Arterial Hypertension via Synergistic Blockade of Vascular RemodelingMengqi Li, Yu Wang, Xinru Liang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2024
Inhibition of breast cancer growth with AN-329, a novel Hsp110 inhibitor, by inactivating p-STAT3/c-Myc axisJunnan Li, Ruizhe Gao, Congke Zhao, et al.
Journal of Medicinal Chemistry|December 13, 2025
Design and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting Extracellular Matrix Dysregulation and Vasodilation for the Treatment of Pulmonary Arterial HypertensionYuanbo Hu, Yu Wang, Wenhua Tan, et al.
Journal of Medicinal Chemistry|April 22, 2026
Identification of Nitric Oxide-Donating Lenumlostat Derivatives with Dual Activities of Extracellular Matrix Dysregulation Inhibition and Pulmonary Vasodilation for the Treatment of Pulmonary Arterial HypertensionYuanbo Hu, Yu Wang, Wenhua Tan, et al.
Frontiers in Microbiology|December 17, 2024
Molecular characteristics, clonal transmission, and risk factors of <i>Clostridioides difficile</i> among hospitalized patients in a tertiary hospital in Ningbo, ChinaLiqing Hu, Shan Lin, Meng Zhang, et al.
Nature Communications|May 12, 2023
A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungiLiqing Hu, Cancan Sun, Justin M Kidd, et al.
Pageof 6